Overview
Modifier JW carries the CMS descriptor "drug amount discarded/not administered to any patient" and has been in the HCPCS file since January 1, 2003. Its purpose is payment, not just reporting: when a provider must throw away the rest of a single-dose container after giving a dose to a Medicare patient, Medicare pays for the discarded amount as well as the dose, up to the amount stated on the vial or package label. Chapter 17, section 40 of the Medicare Claims Processing Manual has required A/B MACs to identify those discarded amounts with JW since January 1, 2017, and since July 1, 2023 the absence of waste is reported with the companion modifier JZ.
The manual defines the discarded amount as the labeled amount of the container, or containers, minus the prescribed dose. Drug that has to be drawn up or left in the vial to give the dose still counts as discarded if it was not part of the dose and was not meant to have a therapeutic effect. The claim then carries two lines with the same HCPCS code: one with no modifier and the units administered, and one with JW and the units discarded. Both lines are processed for payment, and the discarded amount has to be recorded in the patient's medical record, which is the first thing an auditor compares the JW units against.
JW is not allowed in every waste situation. It never applies to drugs from multiple-dose containers. It is also barred when the billing unit already covers the whole amount: if one unit represents 10 mg and a 7 mg dose is given from a 10 mg vial, the single unit pays for the full 10 mg, so a JW line for the other 3 mg would pay twice; JZ is used instead. Drugs that are not separately payable, such as packaged OPPS or ASC drugs and drugs given in an FQHC or RHC, are outside the policy, as are the section 1861(s)(10) vaccines. Since January 1, 2025, a supplier that dispenses but does not administer a drug reports JW for amounts discarded while preparing it.
Two narrower uses survive from older policy. Method I home dialysis facilities use JW for erythropoiesis-stimulating agents a patient had to discard, and claims under the Part B drug competitive acquisition program, postponed since January 1, 2009, did not use JW. Because CMS now uses JW and JZ data to calculate manufacturer refunds for discarded drug, an accurate JW line also documents the waste a manufacturer may owe for.
Worked example
A clinic gives 76 mg of a biologic supplied in a 100 mg single-dose vial whose HCPCS billing unit is 1 mg. The remaining 24 mg cannot be used for another patient and is discarded. The claim carries the HCPCS code with 76 units and no modifier, and the same code with modifier JW and 24 units. The administration note records the vial size, the 76 mg dose and the 24 mg wasted, so the two lines add up to the 100 mg on the label.
Look it up in CMS data
Free reference pages and tools rebuilt from the current CMS release files, for looking up the CMS data behind this term.
Frequently asked questions — Modifier JW (Drug Amount Discarded)
Does Medicare pay for the units billed with JW?
Yes. Medicare pays for the discarded amount of a single-dose container drug in addition to the dose administered, up to the amount on the label, as long as the waste is documented and the JW line meets the conditions in chapter 17, section 40 of the Claims Processing Manual.
When is the JW modifier not allowed?
JW is not allowed for multiple-dose containers, for drugs that are not separately payable (packaged OPPS or ASC drugs, drugs given in an FQHC or RHC), for the section 1861(s)(10) vaccines, or when one billing unit already covers the dose plus the remainder. In that last case the single unit is billed with JZ.
What is the difference between JW and JZ?
JW reports discarded drug on its own claim line, which Medicare pays. JZ reports that nothing was discarded and goes on the administered line. For a single-dose container drug, Medicare expects one of the two: an unmodified line plus a JW line, or a JZ line.
What documentation supports a JW line?
The medical record has to show the amount discarded, and in practice the container size, the dose given and who prepared it. Auditors compare the JW units with those entries and with the drug's billing unit, so the arithmetic should be visible in the chart.
Disclaimer
This glossary entry is operational reference for revenue-cycle and medical-billing professionals. It is not legal, clinical, or contractual advice. Industry benchmarks cite named public sources where available; always verify against the current guidance from the authority body before relying on a number in a contract, policy, or compliance filing.